II) Thoracic Surgery

​A. Lung Cancer

A.1. Lung Cancer

A.1.a. NCCN 2018: Lung Cancer Screening

A.1.b. CHEST 2018: Screening for Lung Cancer CHEST Guideline and Expert Panel Report

A.1.c. CHEST 2013: Executive Summary

A.1.d. CHEST 2013: Methodology for Development of Guidelines for Lung Cancer

A.1.e. CHEST 2013: Epidemiology of Lung Cancer

A.1.f. CHEST 2013: Molecular Biology of Lung Cancer

A.1.g. CHEST 2013: Chemoprevention of Lung Cancer

A.1.h. CHEST 2013: Treatment of Tobacco Use in Lung Cancer

A.1.i. CHEST 2013: Screening for Lung Cancer

A.1.j. CHEST 2013: Evaluation of Individuals With Pulmonary Nodules: When Is It Lung Cancer?

A.1.k. CHEST 2013: Clinical and Organizational Factors in the Initial Evaluation of Patients With Lung Cancer

A.1.l. CHEST 2013: Establishing the Diagnosis of Lung Cancer

A.1.m. CHEST 2013: Physiologic Evaluation of the Patient With Lung Cancer Being Considered for Resectional Surgery

A.1.n. CHEST 2013: The Stage Classification of Lung Cancer

A.1.o. CHEST 2013: Diagnostic Surgical Pathology in Lung Cancer

A.1.p CHEST 2013: Diagnosis and Treatment of Bronchial Intraepithelial Neoplasia and Early Lung Cancer of the Central Airways

A.1.q. CHEST 2013: Palliative and End-of-Life Care in Lung Cancer

A.1.r. CHEST 2013: Symptom Management in Patients With Lung Cancer

A.1.s. CHEST 2013: Follow-up and Surveillance of the Patient With Lung Cancer After Curative-Intent Therapy

A.1.t. CHEST 2013: Complementary Therapies and Integrative Medicine in Lung Cancer

A.2. Small Cell Lung Cancer

A.2.a. NCCN 2018: Small Cell Lung Cancer

A.2.b. CHEST 2013: Treatment of Small Cell Lung Cancer

A.3. Non-Small Cell Lung Cancer

A.3.a. NCCN 2018: Non-Small Cell Lung Cancer

A.3.b. CHEST 2013: Treatment of Stage I and II Non-small Cell Lung Cancer

A.3.c. CHEST 2013: Methods for Staging Non-small Cell Lung Cancer

A.3.d. CHEST 2013: Treatment of Stage III Non-small Cell Lung Cancer

A.3.e. CHEST 2013: Treatment of Stage IV Non-small Cell Lung Cancer

A.3.f. CHEST 2013: Special Treatment Issues in Non-small Cell Lung Cancer

A.3.g. CHEST 2012: Evaluation and Management for High-Risk Patients With Stage I Non-small Cell Lung Cancer

B. Esophageal Cancer

B.1. NCCN 2018: Esophageal and Esophagogastric Junction Cancers

B.2. STS 2013: Diagnosis and Staging of Patients With Esophageal Cancer

B.3. STS 2009: Management of Barrett’s Esophagus with High-Grade Dysplasia

B.4. STS 2014: Multimodality Treatment for Cancer of the Esophagus and Gastroesophageal Junction

C. Mesothelioma

C.1. NCCN 2018:  Malignant Pleural Mesothelioma

D. Thymoma

D.1. NCCN 2018: Thymomas and Thymic Carcinomas